Status:
COMPLETED
Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery
Lead Sponsor:
Medical University of Vienna
Conditions:
Valvular Heart Disease
Coronary Artery Disease
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
The aim of the study is to compare three different regimens for volume replacement during cardiac surgery, e.g. Albumin 5%, Hydroxyethylstarch 130/0.4 (HES) and Ringer-Lactate (RL). Main Outcome para...
Eligibility Criteria
Inclusion
- Valve replacement
- Coronary bypass surgery
Exclusion
- Severe left ventricular dysfunction
- Coagulation disorders
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01174719
Start Date
March 1 2006
End Date
April 1 2010
Last Update
April 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna General Hospital
Vienna, Vienna, Austria, 1090